Vera Huang is a prominent inventor based in El Cerrito, California. She has made significant contributions to the field of medical diagnostics and therapy, particularly in the area of tumor treatment. Her innovative work focuses on the development of antibodies that can effectively bind to tumor tissue.

Latest Patents

Vera Huang holds a patent for "Antibodies that bind tumor tissue for diagnosis and therapy." This patent describes antibodies that interact with an extracellular RNA-protein complex found in tumor tissue. These antibodies are instrumental in methods aimed at inducing an immune response and inhibiting tumor cell growth. Additionally, the patent outlines methods for producing these antibodies, showcasing her commitment to advancing cancer treatment.

Career Highlights

Vera Huang is currently associated with Atreca, Inc., a company dedicated to developing innovative immunotherapies. Her work at Atreca has positioned her as a key player in the biotechnology sector, where she continues to push the boundaries of cancer research and treatment.

Collaborations

Throughout her career, Vera has collaborated with notable colleagues, including Jeff DeFalco and Daniel Eric Emerling. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking therapies.

Conclusion

Vera Huang's contributions to the field of tumor diagnosis and therapy exemplify her dedication to innovation in medical science. Her work not only advances our understanding of cancer treatment but also holds the potential to improve patient outcomes significantly.

Profile summary based on public USPTO records.